NASDAQ:SIEN - Sientra Stock Price, Forecast & News

Sientra trades on the NASDAQ under the ticker symbol "SIEN."

Sientra Inc (NASDAQ:SIEN) announced its quarterly earnings results on Thursday, November, 7th. The medical instruments supplier reported ($0.45) EPS for the quarter, beating the consensus estimate of ($0.47) by $0.02. The medical instruments supplier had revenue of $22.41 million for the quarter, compared to analyst estimates of $20.05 million. Sientra had a negative return on equity of 122.95% and a negative net margin of 143.76%. The business's revenue for the quarter was up 32.8% on a year-over-year basis. During the same quarter last year, the firm posted ($0.72) earnings per share. View Sientra's Earnings History.

Sientra is scheduled to release their next quarterly earnings announcement on Wednesday, March 11th 2020. View Earnings Estimates for Sientra.

Sientra will be holding an earnings conference call on Wednesday, March 11th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Sientra issued an update on its fourth quarter 2019 Pre-Market earnings guidance on Monday, January, 13th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $23.2-23.2 million, compared to the consensus revenue estimate of $22.74 million.

8 brokerages have issued 12-month price targets for Sientra's stock. Their forecasts range from $10.00 to $27.00. On average, they anticipate Sientra's stock price to reach $15.75 in the next year. This suggests a possible upside of 260.4% from the stock's current price. View Analyst Price Targets for Sientra.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sientra in the last year. There are currently 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sientra.

Headlines about SIEN stock have been trending somewhat positive this week, according to InfoTrie Sentiment. The research group identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Sientra earned a coverage optimism score of 1.5 on InfoTrie's scale. They also assigned media stories about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Sientra.

Some companies that are related to Sientra include Establishment Labs (ESTA), RTI Surgical (RTIX), Invacare (IVC), Lakeland Industries (LAKE), ConforMIS (CFMS), COLLPLANT HOLDI/S (CLGN), Histogenics (HSGX), Allied Healthcare Products (AHPI), NanoVibronix (NAOV), Bionik Laboratories (BNKL), Rewalk Robotics (RWLK), Precision Therapeutics (POAI), Ocugen (OCGN) and Avitar (AVTI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Sientra investors own include Genocea Biosciences (GNCA), Verizon Communications (VZ), Novavax (NVAX), Rigel Pharmaceuticals (RIGL), Regions Financial (RF), Baidu (BIDU), ChemoCentryx (CCXI), Idera Pharmaceuticals (IDRA), Opko Health (OPK) and AbbVie (ABBV).

Sientra's stock is owned by many different of institutional and retail investors. Top institutional investors include UBS Group AG (4.84%), Schroder Investment Management Group (3.78%), Bamco Inc. NY (2.84%), Goldman Sachs Group Inc. (2.61%), Broadfin Capital LLC (2.60%) and UBS Asset Management Americas Inc. (2.16%). Company insiders that own Sientra stock include Jeffrey M Nugent, Keith J Sullivan, Patrick F Williams, Paul Sean Little, R Scott Greer and Timothy Haines. View Institutional Ownership Trends for Sientra.

SIEN stock was sold by a variety of institutional investors in the last quarter, including Broadfin Capital LLC, J. Goldman & Co LP, UBS Group AG, Barclays PLC, Bamco Inc. NY, Schroder Investment Management Group, Millrace Asset Group Inc. and Private Advisor Group LLC. View Insider Buying and Selling for Sientra.

SIEN stock was acquired by a variety of institutional investors in the last quarter, including Monarch Partners Asset Management LLC, EAM Investors LLC, Assenagon Asset Management S.A., EAM Global Investors LLC, State Street Corp, Marshall Wace North America L.P., Granite Point Capital Management L.P. and Bank of New York Mellon Corp. Company insiders that have bought Sientra stock in the last two years include Jeffrey M Nugent, Keith J Sullivan, Patrick F Williams, Paul Sean Little, R Scott Greer and Timothy Haines. View Insider Buying and Selling for Sientra.

Shares of SIEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of SIEN stock can currently be purchased for approximately $4.37.

Sientra has a market capitalization of $216.24 million and generates $68.13 million in revenue each year. The medical instruments supplier earns $-82,630,000.00 in net income (profit) each year or ($3.25) on an earnings per share basis. Sientra employs 259 workers across the globe.View Additional Information About Sientra.

The official website for Sientra is http://www.sientra.com/.

Sientra's mailing address is 420 SOUTH FAIRVIEW AVENUE SUITE 200, SANTA BARBARA CA, 93117. The medical instruments supplier can be reached via phone at 805-562-3500 or via email at [email protected]